Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer.

被引：0
|
作者：
Peixoto, Renata D'Alpino
Kumar, Aalok
Gill, Sharlene
Lim, Howard John
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.753
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
753
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Evaluation of the CpG island methylator phenotype as a predictive biomarker for adjuvant oxaliplatin-based chemotherapy in colorectal cancer.
    Shiovitz, Stacey
    Wu, Chen
    Yu, Ming
    Gourgioti, Georgia
    Raptou, Georgia
    Kotoula, Vassiliki
    Pentheroudakis, George E.
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [23] Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
    Kang, Mee-Young
    Paik, Jin-Hee
    Ryu, Chun-Geun
    Hwang, Dae-Yong
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 101 (03) : 160 - 166
  • [24] Features of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
    Argyriou, A.
    Polychronopoulos, P.
    Iconomou, G.
    Koutras, A.
    Gourzis, P.
    Assimakopoulos, K.
    Kalofonos, H.
    Chroni, E.
    JOURNAL OF NEUROLOGY, 2007, 254 : 111 - 111
  • [25] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Impact of BRCAness on the efficacy of oxaliplatin-based chemotherapy in patients with unresectable pancreatic cancer.
    Kondo, Tomohiro
    Kanai, Masashi
    Kou, Tadayuki
    Sakuma, Tomohiro
    Mochizuki, Hiroaki
    Kamada, Mayumi
    Nakatsui, Masahiko
    Uza, Norimitsu
    Kodama, Yuzo
    Masui, Toshihiko
    Takaori, Kyoichi
    Matsumoto, Shigemi
    Miyake, Hidehiko
    Okuno, Yasushi
    Muto, Manabu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [27] Impact of pelvis irradiation on toxicity of further oxaliplatin-based chemotherapy in rectal cancer.
    Spalek, Mateusz
    Michalski, Wojciech
    Bujko, Krzysztof
    Wyrwicz, Lucjan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] PERIPHERAL NEUROPATHY: COMPLICATION AFTER OXALIPLATIN-BASED CHEMOTHERAPY FOR COLORECTAL CANCER
    Banach, Marta
    Zygulska, Aneta
    Krzemieniecki, Krzysztof
    MUSCLE & NERVE, 2015, 52 : S49 - S49
  • [29] Multiple Liver Lesions After Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Shlomai, Amir
    Tobar, Ana
    Benjaminov, Ofer
    GASTROENTEROLOGY, 2015, 149 (06) : E1 - E3
  • [30] Uneven Distribution of Histologic Changes of "Blue Liver" Induced After Oxaliplatin-Based Chemotherapy for Colon Cancer
    Fujii, Akiko
    Tateoka, Teppei
    Okuyama, Takashi
    Matsushima, Jun
    Sato, Taiki
    Ono, Yuko
    Ban, Shinichi
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (05) : 523 - 525
12345